• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: a mathematical model.糖尿病足溃疡远程监测筛查的成本效益:一个数学模型
CMAJ Open. 2018 Oct 18;6(4):E486-E494. doi: 10.9778/cmajo.20180088. Print 2018 Oct-Dec.
2
Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.糖尿病足防治的成本效益:马尔可夫分析
Diabetes Care. 2004 Apr;27(4):901-7. doi: 10.2337/diacare.27.4.901.
3
Tibial nerve decompression for the prevention of the diabetic foot: a cost-utility analysis using Markov model simulations.应用马尔可夫模型模拟进行胫骨神经减压术以预防糖尿病足:成本-效用分析
BMJ Open. 2019 Mar 15;9(3):e024816. doi: 10.1136/bmjopen-2018-024816.
4
Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.贝卡普勒明在四个欧洲国家治疗糖尿病足溃疡的成本效益
Pharmacoeconomics. 2001;19(7):767-78. doi: 10.2165/00019053-200119070-00005.
5
Cost-effectiveness of telemonitoring of diabetic foot ulcer patients.糖尿病足溃疡患者远程监测的成本效益。
Health Informatics J. 2018 Sep;24(3):245-258. doi: 10.1177/1460458216663026. Epub 2016 Sep 16.
6
Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment.高压氧疗法治疗糖尿病足溃疡:一项卫生技术评估。
Ont Health Technol Assess Ser. 2017 May 12;17(5):1-142. eCollection 2017.
7
Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.与尿白蛋白排泄率相比,使用 CKD273 尿肽分类器筛查 2 型糖尿病患者慢性肾脏病进展的成本效益。
Nephrol Dial Transplant. 2018 Mar 1;33(3):441-449. doi: 10.1093/ndt/gfx068.
8
An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.一种基于证据的模型,用于比较富血小板血浆凝胶与其他疗法治疗糖尿病足溃疡不愈合患者的成本效益。
Adv Skin Wound Care. 2008 Dec;21(12):568-75. doi: 10.1097/01.ASW.0000323589.27605.71.
9
Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.德国高危人群潜在肺癌筛查计划的成本效用分析:一种建模方法。
Lung Cancer. 2018 Oct;124:189-198. doi: 10.1016/j.lungcan.2018.07.036. Epub 2018 Jul 24.
10
Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US.在美国,使用辅助性猪小肠黏膜下层三层基质与标准护理相比治疗糖尿病足溃疡的成本效益。
J Wound Care. 2017 Jan 2;26(Sup1):S12-S24. doi: 10.12968/jowc.2017.26.Sup1.S12.

引用本文的文献

1
The Impact of Underlying Conditions on Quality-of-Life Measurement Among Patients with Chronic Wounds, as Measured by Utility Values: A Review with an Additional Study.基础条件对慢性伤口患者生命质量测量的影响:基于效用值的评估——一项综述及补充研究。
Adv Wound Care (New Rochelle). 2023 Dec;12(12):680-695. doi: 10.1089/wound.2023.0098. Epub 2023 Oct 9.
2
Development and Usability Evaluation of a Telemedicine System for Management and Monitoring of Patients with Diabetic Foot.用于糖尿病足患者管理与监测的远程医疗系统的开发与可用性评估
Healthc Inform Res. 2022 Jan;28(1):77-88. doi: 10.4258/hir.2022.28.1.77. Epub 2022 Jan 31.
3
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.糖尿病周围神经病变和下肢疾病的流行病学。
Curr Diab Rep. 2019 Aug 27;19(10):86. doi: 10.1007/s11892-019-1212-8.
4
Assessing the Need for Mobile Health (mHealth) in Monitoring the Diabetic Lower Extremity.评估移动医疗(mHealth)在监测糖尿病下肢方面的需求。
JMIR Mhealth Uhealth. 2019 Apr 16;7(4):e11879. doi: 10.2196/11879.

本文引用的文献

1
Diabetic Foot Ulcers and Their Recurrence.糖尿病足溃疡及其复发
N Engl J Med. 2017 Jun 15;376(24):2367-2375. doi: 10.1056/NEJMra1615439.
2
Recurrent and other new foot ulcers after healed plantar forefoot diabetic ulcer.足底前足糖尿病溃疡愈合后复发及其他新发足部溃疡。
Wound Repair Regen. 2017 Apr;25(2):309-315. doi: 10.1111/wrr.12522. Epub 2017 Apr 27.
3
A Systematic Review of the Use of Telemedicine in Plastic and Reconstructive Surgery and Dermatology.远程医疗在整形与重建外科及皮肤科应用的系统评价
Ann Plast Surg. 2017 Jun;78(6):736-768. doi: 10.1097/SAP.0000000000001044.
4
Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.支持糖尿病患者护理的移动应用程序的疗效:随机对照试验的系统评价和荟萃分析
JMIR Mhealth Uhealth. 2017 Mar 1;5(3):e4. doi: 10.2196/mhealth.6309.
5
A Shared Decision-Making Approach to Telemedicine: Engaging Rural Patients in Glycemic Management.远程医疗的共同决策方法:让农村患者参与血糖管理
J Clin Med. 2016 Nov 17;5(11):103. doi: 10.3390/jcm5110103.
6
Cost-effectiveness of telemonitoring of diabetic foot ulcer patients.糖尿病足溃疡患者远程监测的成本效益。
Health Informatics J. 2018 Sep;24(3):245-258. doi: 10.1177/1460458216663026. Epub 2016 Sep 16.
7
The Role of Telemedicine in Wound Care: A Review and Analysis of a Database of 5,795 Patients from a Mobile Wound-Healing Center in Languedoc-Roussillon, France.远程医疗在伤口护理中的作用:对法国朗格多克-鲁西永一个移动伤口愈合中心的5795例患者数据库的回顾与分析
Plast Reconstr Surg. 2016 Sep;138(3 Suppl):248S-256S. doi: 10.1097/PRS.0000000000002702.
8
Comment on Rasmussen et al. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care 2015;38:1723-1729.对拉斯穆森等人的评论。一项比较糖尿病足溃疡远程医疗与标准门诊监测的随机对照试验。《糖尿病护理》2015年;38:1723 - 1729。
Diabetes Care. 2016 Jan;39(1):e9-10. doi: 10.2337/dc15-1659.
9
Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review.糖尿病高危患者足部溃疡的预防:系统评价。
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:84-98. doi: 10.1002/dmrr.2701.
10
IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes.国际糖尿病足工作组关于糖尿病高危患者足部溃疡预防的指南。
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:16-24. doi: 10.1002/dmrr.2696.

糖尿病足溃疡远程监测筛查的成本效益:一个数学模型

Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: a mathematical model.

作者信息

Boodoo Chris, Perry Julie A, Leung General, Cross Karen M, Isaranuwatchai Wanrudee

机构信息

Department of Medical Imaging (Boodoo, Leung), Division of Plastic Surgery (Perry, Cross), Centre for Excellence in Economic Analysis Research (Isaranuwatchai) and Keenan Research Centre for Biomedical Science (Leung, Cross), St. Michael's Hospital; Institute of Health Policy, Management and Evaluation (Isaranuwatchai), University of Toronto, Toronto, Ont.

出版信息

CMAJ Open. 2018 Oct 18;6(4):E486-E494. doi: 10.9778/cmajo.20180088. Print 2018 Oct-Dec.

DOI:10.9778/cmajo.20180088
PMID:30337474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6201712/
Abstract

BACKGROUND

One of the most common (and costly) complications of diabetes are diabetic foot ulcers, which often result in lower-extremity amputation. Regular foot care can reduce complications; however, roughly half of Canadians with diabetes do not participate in screening. We sought to evaluate the economic effects of using telemonitoring for diabetic foot ulcer prevention using mathematical modelling.

METHODS

We used Markov modelling to compare current screening standards (standard care) to population-wide and targeted (high-risk) telemonitoring programs in a hypothetical cohort of Canadian patients aged 60 years. We varied the effectiveness (or outcome), defined as the proportion of diabetic foot ulcers prevented, to explore cost-effectiveness using model parameters from published literature and clinical experts.

RESULTS

At 20%-40% effectiveness, population-based prevention resulted in 0.00399-0.00790 quality-adjusted life years (QALYs) gained per person over 5 years and an incremental cost of $479-$402 compared to standard care. At 15%-40% effectiveness, high-risk prevention resulted in a cost decrease per person over 5 years ($1.26-$25.55), with health benefits of 0.000207-0.00058 QALYs gained.

INTERPRETATION

The use of telemonitoring in the diabetic lower extremity can offer patients better quality of life and can be cost-effective compared to current Canadian screening practices. Future work should focus on developing and validating technologies based on objective outcome measures for remote monitoring of the diabetic foot.

摘要

背景

糖尿病最常见(且代价高昂)的并发症之一是糖尿病足溃疡,其常导致下肢截肢。定期足部护理可减少并发症;然而,约一半的加拿大糖尿病患者未参与筛查。我们试图通过数学建模评估使用远程监测预防糖尿病足溃疡的经济效果。

方法

我们使用马尔可夫模型,在一个假设的60岁加拿大患者队列中,将当前的筛查标准(标准护理)与全人群和针对性(高危人群)远程监测项目进行比较。我们改变有效性(或结果),定义为预防的糖尿病足溃疡比例,利用已发表文献和临床专家的模型参数来探索成本效益。

结果

在有效性为20%-40%时,基于人群的预防措施在5年内每人获得0.00399-0.00790个质量调整生命年(QALY),与标准护理相比,增量成本为479-402美元。在有效性为15%-40%时,高危人群预防措施在5年内每人成本降低(1.26-25.55美元),获得的健康效益为0.000207-0.00058个QALY。

解读

在糖尿病下肢护理中使用远程监测可为患者提供更好的生活质量,与加拿大目前的筛查做法相比,具有成本效益。未来的工作应侧重于基于客观结果指标开发和验证用于糖尿病足远程监测的技术。